z-logo
open-access-imgOpen Access
Simultaneous and Trace Level Determination of Six Potential Impurities by UPLC-ESI-MS/MS in Antiarrhythmic Drug: Dronedarone Hydrochloride
Author(s) -
K. Durga Raja,
V. Saradhi Venkata Ramana,
K. Raghu Babu,
B. Babu,
Vundavilli Jagadeesh Kumar,
Karunesh Kumar,
Hemant Sharma
Publication year - 2020
Publication title -
asian journal of chemistry/asian journal of chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.145
H-Index - 34
eISSN - 0975-427X
pISSN - 0970-7077
DOI - 10.14233/ajchem.2020.22588
Subject(s) - chemistry , chromatography , impurity , formic acid , dronedarone , high performance liquid chromatography , methanol , detection limit , analytical chemistry (journal) , atrial fibrillation , medicine , amiodarone , organic chemistry , cardiology
Development and validation of six potential impurities by ultra performance liquid chromatographyelectro spray ionization tandem mass (UPLC-ESI-MS/MS) method for dronedarone hydrochloridedrug was accomplished coherent with ICH guidelines. Successful chromatographic separation ofdronedarone with its six impurities was attained by using gradient elution mode on RP-UPLC columnusing three pump mode system of 0.1 % formic acid in water as mobile phase A, methanol as themobile phase B and solvent mixture of methanol, acetonitrile and water in the ratio of 65:30:5 v/v/v asthe mobile phase C. Chromatographic conditions were set as 0.3 mL min-1 flow rate at the columntemperature of 45 °C with the injection volume 2 μL. Briefly, the method enabled quantitation of siximpurities with high accuracy (recovery > 90 %) and precision (% RSD < 5.0),within the ranges of0.18-2.82 μg g-1. The regression (r) for each impurity over a range was > 0.99. The detection limit andquantitation limit of impurities were set at 0.09 and 0.18 μg g-1, respectively. The performed validationtests proved the suitability of the method for its intended purposes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here